Non‐parallel anti‐tumour effects of pembrolizumab: a case of cardial tamponade

We present the case of a 70‐year‐old man with stage IV lung adenocarcinoma. He was treated with pembrolizumab, a programmed cell death‐1 (PD‐1) inhibitor, as a first‐line therapy. After six cycles of pembrolizumab, he suddenly developed cardiac tamponade. With the exception of newly massive malignan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tachihara, Motoko, Yamamoto, Masatsugu, Yumura, Masako, Yoshizaki, Asuka, Kobayashi, Kazuyuki, Nishimura, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354230/
https://www.ncbi.nlm.nih.gov/pubmed/30733865
http://dx.doi.org/10.1002/rcr2.404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354230/
https://www.ncbi.nlm.nih.gov/pubmed/30733865
http://dx.doi.org/10.1002/rcr2.404

Ejemplares similares